The Minnesota-based company, founded in 2012, uses its resosphere resorbable embolic microsphere technology to develop embolization and resorbable particles that selectively block arteries by introducing emboli, allowing doctors and surgeons to thread a catheter into the artery that needs to be closed off, with the aim of treating multiple indications.